期刊文献+
共找到110篇文章
< 1 2 6 >
每页显示 20 50 100
聚合物纳米粒子的结构和性能对胞吞和细胞功能的影响 被引量:15
1
作者 胡玲 张裕英 高长有 《化学进展》 SCIE CAS CSCD 北大核心 2009年第6期1254-1267,共14页
随着纳米医学的发展,越来越多的聚合物纳米粒子被用作荧光探针和药物或基因的载体,在生物分析、检测以及药物传输和基因治疗等领域得到应用。细胞的胞吞是细胞将细胞外基质、病毒、微组织或纳米粒子运送到细胞内部的一个重要生理过程。... 随着纳米医学的发展,越来越多的聚合物纳米粒子被用作荧光探针和药物或基因的载体,在生物分析、检测以及药物传输和基因治疗等领域得到应用。细胞的胞吞是细胞将细胞外基质、病毒、微组织或纳米粒子运送到细胞内部的一个重要生理过程。研究细胞对纳米粒子的胞吞,有助于从细胞层次上理解生命现象,掌握细胞内治疗的机理。本文综述了近几年来细胞和聚合物纳米粒子之间相互作用的最新研究结果。首先介绍了用于胞吞研究的常用聚合物纳米粒子体系及其功能化方法,尤其是荧光探针的复合与表面修饰。进而介绍了细胞和聚合物纳米粒子之间相互作用的基本过程,包括聚合物纳米粒子在细胞转运过程中的驱动力、细胞内转运过程、在细胞中的分布及其细胞毒性。对影响聚合物纳米微粒胞吞的因素如纳米粒子浓度、共培养时间、纳米粒子性能(形状、粒径、电荷和PEG修饰)、细胞类型和培养条件等进行了总结。最后重点介绍了用于受体介导细胞胞吞的聚合物纳米粒子体系,指出了目前研究工作中的不足及未来发展方向。 展开更多
关键词 胞吞 纳米粒子 聚合物 受体介导
原文传递
脑靶向递药系统的研究进展 被引量:12
2
作者 蒋新国 《复旦学报(医学版)》 CAS CSCD 北大核心 2012年第5期441-448,共8页
血脑屏障上存在诸多受体和转运体,如转铁蛋白受体、低密度脂蛋白受体和己糖转运体等。采用其相应的配体或抗体修饰可构建脑靶向递药系统,有望提高脑组织的药物浓度,增强对脑部疾病的治疗效果,降低毒性作用及不良反应。此外,利用正负电... 血脑屏障上存在诸多受体和转运体,如转铁蛋白受体、低密度脂蛋白受体和己糖转运体等。采用其相应的配体或抗体修饰可构建脑靶向递药系统,有望提高脑组织的药物浓度,增强对脑部疾病的治疗效果,降低毒性作用及不良反应。此外,利用正负电荷的吸附介导和鼻腔给药也可能增加药物的脑内递送。 展开更多
关键词 脑靶向 递药系统 受体介导 吸附介导 转运体介导 鼻腔给药
下载PDF
受体介导的肿瘤靶向治疗研究进展 被引量:5
3
作者 陈慧 李娟 《药学与临床研究》 2008年第4期288-292,共5页
肿瘤细胞表面过度表达一系列受体,能与特异性的配体结合并诱导细胞内化。以这些受体为作用靶点,使抗肿瘤药物与特异性配体结合即可将药物主动靶向肿瘤细胞。本文就近年来研究较多的受体如唾液酸糖蛋白受体、生长因子受体、低密度酯蛋白... 肿瘤细胞表面过度表达一系列受体,能与特异性的配体结合并诱导细胞内化。以这些受体为作用靶点,使抗肿瘤药物与特异性配体结合即可将药物主动靶向肿瘤细胞。本文就近年来研究较多的受体如唾液酸糖蛋白受体、生长因子受体、低密度酯蛋白受体、转铁蛋白受体、叶酸受体、CD44等进行概述。 展开更多
关键词 受体介导 细胞因子受体 唾液酸糖蛋白受体 低密度酯蛋白受体 转铁蛋白受体 叶酸受体 CD44
下载PDF
中药靶向递药入脑策略的研究进展 被引量:1
4
作者 程怡 刘德文 +7 位作者 欧则民 严林 王艳静 张瑶 王梓丞 仝燕 常鹏飞 王锦玉 《中国现代中药》 CAS 2023年第3期686-694,共9页
血脑屏障是中枢神经系统的一层特殊屏障,调节中枢神经系统稳态,允许正常的神经元功能,保护中枢神经系统免遭毒素、病原体和炎症的侵害。然而,脑毛细血管内皮细胞紧密连接的特性在保护的同时也极大程度限制了药物分子向内的递送效果。近... 血脑屏障是中枢神经系统的一层特殊屏障,调节中枢神经系统稳态,允许正常的神经元功能,保护中枢神经系统免遭毒素、病原体和炎症的侵害。然而,脑毛细血管内皮细胞紧密连接的特性在保护的同时也极大程度限制了药物分子向内的递送效果。近年来,纳米制剂在中药靶向递药领域被广泛应用,较大的系统结构受制于血脑屏障导致疗效并不理想。基于血脑屏障上各种内源性受体及转运蛋白的发现,以及血脑屏障表面荷负电的生理特征,构建安全高效的靶向递药系统,从而设计受体介导、载体介导及吸附介导的转运途径实现血脑屏障的跨越,使药物制剂富集于脑部病变组织,有效提高疾病的治疗效果。受芳香中药“通关开窍”的传统功效启发,阐述其调节血脑屏障通透性的机制,并将这一功效与新兴纳米制剂结合,发挥中药特色进而实现制剂透过血脑屏障入脑释药。 展开更多
关键词 血脑屏障 受体介导 载体介导 吸附介导 芳香开窍
下载PDF
Di-PEGylated insulin:A long-acting insulin conjugate with superior safety in reducing hypoglycemic events
5
作者 Zhipeng Zeng Runcheng Tan +5 位作者 Shi Chen Haolin Chen Zhijia Liu Lixin Liu Mingqiang Li Yongming Chen 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2024年第6期2761-2772,共12页
Although the discovery of insulin 100 years ago revolutionized the treatment of diabetes,its therapeutic potential is compromised by its short half-life and narrow therapeutic index.Current long-acting insulin analogs... Although the discovery of insulin 100 years ago revolutionized the treatment of diabetes,its therapeutic potential is compromised by its short half-life and narrow therapeutic index.Current long-acting insulin analogs,such as insulin-polymer conjugates,are mainly used to improve pharmacokinetics by reducing renal clearance.However,these conjugates are synthesized without sacrificing the bioactivity of insulin,thus retaining the narrow therapeutic index of native insulin,and exceeding the efficacious dose still leads to hypoglycemia.Here,we report a kind of di-PEGylated insulin that can simultaneously reduce renal clearance and receptor-mediated clearance.By impairing the binding affinity to the receptor and the activation of the receptor,di-PEGylated insulin not only further prolongs the half-life of insulin compared to classical mono-PEGylated insulin but most importantly,increases its maximum tolerated dose 10-fold.The target of long-term glycemic management in vivo has been achieved through improved pharmacokinetics and a high dose.This work represents an essential step towards long-acting insulin medication with superior safety in reducing hypoglycemic events. 展开更多
关键词 Diabetes INSULIN Therapeutic index HYPOGLYCEMIA PEGYLATION receptor-mediated clearance HALF-LIFE Diabetic nephropathy
原文传递
突破血脑屏障纳米药物递送系统的研究进展 被引量:4
6
作者 马一星 叶青 《中国药事》 CAS 2016年第2期141-149,共9页
血脑屏障阻碍药物渗透进入中枢神经系统。近年来,纳米递药系统的研究表明,药物-载体可以受体、运载体、吸附介导的胞吞非侵袭手段,或血脑屏障瞬时开放等多种机制跨越血脑屏障并释药达到病灶部位。本文综述了近年来跨血脑屏障纳米递药系... 血脑屏障阻碍药物渗透进入中枢神经系统。近年来,纳米递药系统的研究表明,药物-载体可以受体、运载体、吸附介导的胞吞非侵袭手段,或血脑屏障瞬时开放等多种机制跨越血脑屏障并释药达到病灶部位。本文综述了近年来跨血脑屏障纳米递药系统的研究进展,采用多种策略联合应用,使纳米递药系统存在巨大潜力,开发新型无毒脑靶向纳米制剂和材料将获得极大的发展和应用空间。 展开更多
关键词 血脑屏障 纳米药物递送系统 运载体介导 受体介导 脑靶向 吸附介导
下载PDF
Molecular mechanisms of NMDA receptor-mediated excitotoxicity:implications for neuroprotective therapeutics for stroke 被引量:5
7
作者 Victor Li Yu Tian Wang 《Neural Regeneration Research》 SCIE CAS CSCD 2016年第11期1752-1753,共2页
Excitotoxicity is a process observed in many disease states by which an excessive synaptic excitation causes neuronal death, and is thought to be triggered by the extracellular accumulation of the excitatory neurotran... Excitotoxicity is a process observed in many disease states by which an excessive synaptic excitation causes neuronal death, and is thought to be triggered by the extracellular accumulation of the excitatory neurotransmitter glutamate, which binds and activates ionotropic N-methyl-D-aspartate glutamatergic receptors (NMDARs) in the brain. Normally, NMDARs mediate calcium entry into the cell to regulate physiological processes such as synaptic plasticity and memory, 展开更多
关键词 NMDAR Molecular mechanisms of NMDA receptor-mediated excitotoxicity
下载PDF
The crossroads of receptor-mediated signaling and endocytosis in plants 被引量:5
8
作者 Lucas Alves Neubus Claus Daniel V.Savatin Eugenia Russinova 《Journal of Integrative Plant Biology》 SCIE CAS CSCD 2018年第9期827-840,共14页
Plants deploy numerous plasma membrane receptors to sense and rapidly react to environmental changes. Correct localization and adequate protein levels of the cell-surface receptors are critical for signaling activatio... Plants deploy numerous plasma membrane receptors to sense and rapidly react to environmental changes. Correct localization and adequate protein levels of the cell-surface receptors are critical for signaling activation and modulation of plant development and defense against pathogens. After ligand binding, receptors are internalized for degradation and signaling attenuation. However, one emerging notion is that the Iigand-induced endocytosis of reCeptor complexes is important for the signal duration, amplitude, and specificity. Recently, mutants of maior endocytosis players, including clathrin and dynamin, have been shown to display defects in activation of a subset of signal transduction pathways, implying that signaling in plants might not be solely restricted to the plasma membrane. Here, we summarize the up-to-date knowledge of receptor complex endocytosis and its effect on the signaling outcome, in the context of plant development and immunity. 展开更多
关键词 The crossroads of receptor-mediated signaling and endocytosis in plants BRI PM
原文传递
跨血脑屏障纳米递药系统的研究进展 被引量:3
9
作者 桑丽红 王东凯 《中国药剂学杂志》 2021年第2期41-51,共11页
目的血脑屏障(blood-brain barrier,BBB)是一道天然的生理屏障,可保护中枢神经系统免受外来异物的伤害,同时限制了药物的递送。本文主要介绍纳米粒通过血脑屏障的机制以及近几年纳米粒研究的最新进展。方法以国内外文献为依据,综述纳米... 目的血脑屏障(blood-brain barrier,BBB)是一道天然的生理屏障,可保护中枢神经系统免受外来异物的伤害,同时限制了药物的递送。本文主要介绍纳米粒通过血脑屏障的机制以及近几年纳米粒研究的最新进展。方法以国内外文献为依据,综述纳米粒通过血脑屏障的机制及研究进展。结果与结论药物载体可以通过受体、转运体、吸附介导的胞吞非侵袭手段,或血脑屏障瞬时开放等多种机制跨越血脑屏障并释放药物到达病灶部位。本文综述了近年来跨血脑屏障纳米递药系统的研究进展,为跨血脑屏障药物转运的研究提供新思路。 展开更多
关键词 血脑屏障 纳米载体 受体介导 转运体介导 吸附介导
下载PDF
CD44介导的肿瘤靶向给药技术研究进展 被引量:4
10
作者 鞠安 田吉来 +2 位作者 蒋雯 丁晨静 顾宁 《药学研究》 CAS 2015年第2期63-68,共6页
CD44分子是广泛表达于细胞表面的一类跨膜单链糖蛋白,许多肿瘤细胞高表达了CD44。以CD44为作用受体靶点,将其特异性配体与药物以不同作用方式相结合,可以将药物主动靶向到肿瘤细胞。本文介绍了CD44分子及其受体介导的肿瘤靶向给药,重点... CD44分子是广泛表达于细胞表面的一类跨膜单链糖蛋白,许多肿瘤细胞高表达了CD44。以CD44为作用受体靶点,将其特异性配体与药物以不同作用方式相结合,可以将药物主动靶向到肿瘤细胞。本文介绍了CD44分子及其受体介导的肿瘤靶向给药,重点关注不同载体的给药技术及其效果评价。 展开更多
关键词 CD44 受体介导 肿瘤靶向 递送系统
下载PDF
Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies 被引量:4
11
作者 Peng Liu Caifang Gao +5 位作者 Hongguo Chen Chi Teng Vong Xu Wu Xudong Tang Shengpeng Wang Yitao Wang 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2021年第9期2798-2818,共21页
Inflammatory bowel disease(IBD)is a chronic intestinal disease with painful clinical manifestations and high risks of cancerization.With no curative therapy for IBD at present,the development of effective therapeutics... Inflammatory bowel disease(IBD)is a chronic intestinal disease with painful clinical manifestations and high risks of cancerization.With no curative therapy for IBD at present,the development of effective therapeutics is highly advocated.Drug delivery systems have been extensively studied to transmit therapeutics to inflamed colon sites through the enhanced permeability and retention(EPR)effect caused by the inflammation.However,the drug still could not achieve effective concentration value that merely utilized on EPR effect and display better therapeutic efficacy in the inflamed region because of nontargeted drug release.Substantial researches have shown that some specific receptors and cell adhesion molecules highly expresses on the surface of colonic endothelial and/or immune cells when IBD occurs,ligandmodified drug delivery systems targeting such receptors and cell adhesion molecules can specifically deliver drug into inflamed sites and obtain great curative effects.This review introduces the overexpressed receptors and cell adhesion molecules in inflamed colon sites and retrospects the drug delivery systems functionalized by related ligands.Finally,challenges and future directions in this field are presented to advance the development of the receptor-mediated targeted drug delivery systems for the therapy of IBD. 展开更多
关键词 receptor-mediated target Inflammatory bowel disease Crohn’s disease Ulcerative colitis Drug delivery Cell adhesion molecule Active target Targeted therapy
原文传递
Orange-derived extracellular vesicles nanodrugs for efficient treatment of ovarian cancer assisted by transcytosis effect
12
作者 Feng Long Yao Pan +9 位作者 Jinheng Li Suinan Sha Xiubo Shi Haoyan Guo Chuanqing Huang Qian Xiao Chao Fan Xingmei Zhang Jun-Bing Fan Ying Wang 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2023年第12期5121-5134,共14页
Extracellular vesicles(EVs)have recently received much attention about the application of drug carriers due to their desirable properties such as nano-size,biocompatibility,and high stability.Herein,we demonstrate ora... Extracellular vesicles(EVs)have recently received much attention about the application of drug carriers due to their desirable properties such as nano-size,biocompatibility,and high stability.Herein,we demonstrate orange-derived extracellular vesicles(OEV)nanodrugs(DN@OEV)by modifying cRGD-targeted doxorubicin(DOX)nanoparticles(DN)onto the surface of OEV,enabling significantly enhancing tumor accumulation and penetration,thereby efficiently inhibiting the growth of ovarian cancer.The obtained DN@OEV enabled to inducement of greater transcytosis capability in ovarian cancer cells,which presented the average above 10-fold transcytosis effect compared with individual DN.It was found that DN@OEV could trigger receptor-mediated endocytosis to promote early endosome/recycling endosomes pathway for exocytosis and simultaneously reduce degradation in the early endosomes-late endosomes-lysosome pathway,thereby inducing the enhanced transcytosis.In particular,the zombie mouse model bearing orthotopic ovarian cancer further validated DN@OEV presented high accumulation and penetration in tumor tissue by the transcytosis process.Our study indicated the strategy in enhancing transcytosis has significant implications for improving the therapeutic efficacy of thedrugdelivery system. 展开更多
关键词 Extracellular vesicles TRANSCYTOSIS Cancer treatment Drug delivery system Targeted modification receptor-mediated endocytosis Intracellular trafficking Recycling endosome
原文传递
纳米给药系统脑靶向配体的研究进展 被引量:4
13
作者 任婧 张丹参 《神经药理学报》 2017年第4期17-25,共9页
血脑脊液屏障(blood-cerebrospinal fluid barrier,blood-CSF barrier)的存在成为了脑部疾病给药治疗的阻碍,而靶向制剂可以使药物选择性的集中在病灶区域,增加药物的浓度,降低毒副作用,成为目前关于脑部疾病治疗的热门方向。该文综述... 血脑脊液屏障(blood-cerebrospinal fluid barrier,blood-CSF barrier)的存在成为了脑部疾病给药治疗的阻碍,而靶向制剂可以使药物选择性的集中在病灶区域,增加药物的浓度,降低毒副作用,成为目前关于脑部疾病治疗的热门方向。该文综述了近五年内应用较广泛的几大类脑靶向配体和其递送策略。搭载药物的纳米粒子通过受体介导、载体介导、转胞吞作用等不同的方式进行跨膜转运,将药物递送至脑部,使药物在脑内蓄积成为可能,并具有极大的研究和发展前景。 展开更多
关键词 血脑脊液屏障 纳米粒子给药系统 靶向药物 受体介导
下载PDF
A novel receptor-targeted gene delivery system for cancer gene therapy 被引量:1
14
作者 田培坤 任圣俊 +4 位作者 任常春 滕青山 曲淑敏 姚明 顾健人 《Science China(Life Sciences)》 SCIE CAS 1999年第2期216-226,共11页
Some growth factor receptors, such as insulin like growth factor I and II receptor (IGF I R, IGF II R) and epidermal growth factor receptor (EGF R), have been proved to be over-expressed in a variety of human cancers ... Some growth factor receptors, such as insulin like growth factor I and II receptor (IGF I R, IGF II R) and epidermal growth factor receptor (EGF R), have been proved to be over-expressed in a variety of human cancers derived from different tissue origins. Based on this molecular alteration, a polypeptide conjugate gene delivery system was designed and synthesized. It contains three essential moieties: a ligand oligopeptide (LOP) for receptor recognition, a polycationic polypeptide (PCP) such as protamine (PA) or poly-L-lysine (PL) as a backbone for DNA binding and an endosome-releasing oligopeptide (EROP) such as influenza haemagglutinin oligopeptide (HA20) for endosomol-ysis. These components are covalently conjugated as LOP-PCP-HA20 or in the form of a mixture of LOP-PCP and HA20-PCP. A 14 amino acid E5 was designed and synthesized as LOP for IGF I R and IGF II R, and a 16 amino acid GE7 as LOP for EGF R. Both E5 and GE7 systems could form stable complex with the plasmid DNA as E5-PCP/ DNA/PCP-HA20 and GE7-PCP/DNA/PCP-HA20. Using bacterial β-galactosidase gene (pSVβ-gal) as a reporter, the present system is able to efficiently target exogenous gene to human cancer cells of different tissue types with high efficiency both in vitro and in implanted tumors in nude mice. It was also demonstrated that the transduced genes were highly expressed in cancer cells both in vitro and in vivo . The present system will provide a novel effective vehicle to target therapeutic genes into cancer cells in gene therapy. 展开更多
关键词 E5 GE7 TARGETING GENE delivery system receptor-mediated cancer.
原文传递
Asialoglycoprotein receptor and liposome synergistically mediate the gene transfer into primary rat hepatocytes
15
作者 李崇辉 温守明 +1 位作者 翟海峰 孙曼霁 《Science China(Life Sciences)》 SCIE CAS 1999年第4期435-440,共6页
Gene transfer into primary rat hepatocytes was performed by employing cationic liposome as DNA carrier and the specific ligand of hepatic asialoglycoprotein receptor (ASGPR), asialofetuin, as liver-targeting ligand. T... Gene transfer into primary rat hepatocytes was performed by employing cationic liposome as DNA carrier and the specific ligand of hepatic asialoglycoprotein receptor (ASGPR), asialofetuin, as liver-targeting ligand. The results showed that asialofetuin, when added to the gene transfer complexes, could significantly increase the hepatocyte transfection efficiency, and alleviate the cellular toxicity of Lipofectin. Several synthetic ligands of ASGPR (galactosyl albumin) could also increase the transfection efficiency of hepatocyte like asialofetuin. It was proved that ASGPR and cationic liposome could synergistically mediate the gene transfer into primary rat hepatocytes. This novel gene delivery system provided a safer, more simple and efficient gene transfer method for primary hepatocytes, and showed prospecting application in hepatic gene therapy. 展开更多
关键词 asialoglycoprotein receptor CATIONIC LIPOSOME receptor-mediated gene transfer primary hepatocyte.
原文传递
基于促性腺激素释放激素类似物的靶向抗肿瘤化合物研究进展 被引量:3
16
作者 马永涛 周宁 刘克良 《国际药学研究杂志》 CAS CSCD 2014年第2期140-148,160,共10页
靶向化疗是一种特异性地将化疗药物靶向到肿瘤部位的治疗方法。由于促性腺激素释放激素(GnRH)受体在大多数肿瘤细胞高表达,而在正常组织或器官上表达很低,因此通过GnRH受体介导的内吞作用将抗癌药物选择性地靶向到肿瘤组织或细胞,可提... 靶向化疗是一种特异性地将化疗药物靶向到肿瘤部位的治疗方法。由于促性腺激素释放激素(GnRH)受体在大多数肿瘤细胞高表达,而在正常组织或器官上表达很低,因此通过GnRH受体介导的内吞作用将抗癌药物选择性地靶向到肿瘤组织或细胞,可提高抗癌药物的疗效。目前GnRH靶向的载药系统已被广泛研究,极大地提高了药物在肿瘤部位的分布,改善了其水溶性、稳定性,避免产生耐药性,延长了药物在体内的循环时间,使毒副作用明显降低。本文就目前基于GnRH类似物的不同抗癌因子的靶向抗肿瘤药物偶联物进行综述。 展开更多
关键词 靶向化疗 受体介导 内吞作用 GNRH类似物
下载PDF
乳铁蛋白作为靶向功能分子的研究进展 被引量:3
17
作者 赵超越 张云杰 +3 位作者 姜晓艺 张颖慧 赵新辰 杨春荣 《中国生化药物杂志》 CAS 北大核心 2014年第9期181-184,共4页
靶向功能基对载药系统主动靶向的效果起着决定性的作用。目前作为主动靶向给药系统的配体很多,如转铁蛋白、叶酸、胰岛素等,而乳铁蛋白是一种更为新型、有效的介导药物脑内递释的靶向功能分子。本文介绍了乳铁蛋白及其受体,并将其与转... 靶向功能基对载药系统主动靶向的效果起着决定性的作用。目前作为主动靶向给药系统的配体很多,如转铁蛋白、叶酸、胰岛素等,而乳铁蛋白是一种更为新型、有效的介导药物脑内递释的靶向功能分子。本文介绍了乳铁蛋白及其受体,并将其与转铁蛋白靶向功能进行比较,综述了近年来国内外学者们将乳铁蛋白作为脑内靶向功能分子的研究进展。 展开更多
关键词 乳铁蛋白 转铁蛋白 受体介导 脑靶向
下载PDF
叶酸受体介导pH敏感型分子靶向阿霉素脂质体的表征与含量测定法的建立 被引量:2
18
作者 夏桂民 安智娇 +2 位作者 赵晨 刘彤 李眉 《药物分析杂志》 CAS CSCD 北大核心 2013年第2期181-184,共4页
目的:表征叶酸受体介导pH敏感型分子靶向阿霉素脂质体,建立RP-HPLC法进行含量测定。方法:采用动态光散射法测定脂质体的粒径;采用液相色谱法开展含量测定的方法学研究与验证。选用Agilent HC-C18色谱柱(250 mm×4.6 mm,5μm),流动相... 目的:表征叶酸受体介导pH敏感型分子靶向阿霉素脂质体,建立RP-HPLC法进行含量测定。方法:采用动态光散射法测定脂质体的粒径;采用液相色谱法开展含量测定的方法学研究与验证。选用Agilent HC-C18色谱柱(250 mm×4.6 mm,5μm),流动相为1.23%醋酸钠水溶液(用冰醋酸调pH至3.3)-甲醇(55∶45),等度洗脱,流速为1.0 mL.min-1,检测波长233 nm,柱温30℃。结果:自制的新型脂质体粒径(120±20)nm(PDI<0.200),包封率不小于91.0%。建立的RP-HPLC法中,自制脂质体的辅料对主峰无干扰,且各杂质峰与主成分峰均能达到基线分离,检测限为0.2 ng(S/N=3),定量限为1.0 ng(S/N=10),主成分的浓度在1.0~40.0μg.mL-1范围内线性良好(r=0.9991)。结论:本文所建方法简便易行,专属性强,灵敏,耐用性好,适于本脂质体中阿霉素的含量测定。 展开更多
关键词 受体介导 PH敏感 盐酸阿霉素 靶向脂质体表征 高效液相色谱 含量测定
原文传递
治疗性抗体在脑部相关疾病中的研究进展 被引量:2
19
作者 张楚麟 刘煜 《药物生物技术》 CAS 2017年第4期359-363,共5页
中枢神经系统疾病越来越严重的危害着人类的健康,由于血脑屏障上脑毛细血管内皮细胞的紧密连接,极大的限制了药物通过血液进入脑组织而发挥作用。目前所研发的传统脑部治疗性抗体临床Ⅲ期结果均不理想,究其原因主要由于抗体主动进入脑... 中枢神经系统疾病越来越严重的危害着人类的健康,由于血脑屏障上脑毛细血管内皮细胞的紧密连接,极大的限制了药物通过血液进入脑组织而发挥作用。目前所研发的传统脑部治疗性抗体临床Ⅲ期结果均不理想,究其原因主要由于抗体主动进入脑内的含量太低未能达到其治疗剂量,因此如何在疾病发现早期使抗体可以稳定、大量的进入血脑屏障(BBB)成为研究的关键。在众多使药物进入脑内的策略中利用血脑屏障自身的转运系统,通过与脑内腔表面特定受体结合经转胞吞作用来转运大分子的转运形式最具有开发前景。临床研究显示靶向转铁蛋白受体(TfR),胰岛素受体(IR)等的抗体可以有效促进药物跨血脑屏障进入脑内发挥作用。因此研发重组抗体成为了抗体治疗中枢神经系统疾病的研究趋势,将治疗性抗体与靶向脑部特异性受体的抗体相"组合"形成具有双功能的治疗性抗体,使其与血脑屏障上特定靶点结合进入脑内并在脑部达到治疗剂量从而发挥作用。文章对治疗脑部疾病的抗体,脑部靶点应用及其研究趋势进行综述。 展开更多
关键词 中枢神经系统疾病 血脑屏障 脑部靶向抗体 基因工程 受体介导 重组抗体
原文传递
A Numerical Study of Passive Receptor-Mediated Endocytosis of Nanoparticles:The Effect of Mechanical Properties 被引量:1
20
作者 Xinyue Liu Yunqiao Liu +1 位作者 Xiaobo Gong Huaxiong Huang 《Computer Modeling in Engineering & Sciences》 SCIE EI 2018年第8期281-300,共20页
In this work,a three-dimensional axisymmetric model with nanoparticle,receptor-ligand bonds and cell membrane as a system was used to study the quasi-static receptor-mediated endocytosis process of spherical nanoparti... In this work,a three-dimensional axisymmetric model with nanoparticle,receptor-ligand bonds and cell membrane as a system was used to study the quasi-static receptor-mediated endocytosis process of spherical nanoparticles in drug delivery.The minimization of the system energy function was carried out numerically,and the deformations of nanoparticle,receptor-ligand bonds and cell membrane were predicted.Results show that passive endocytosis may fail due to the rupture of receptor-ligand bonds during the wrapping process,and the size and rigidity of nanoparticles affect the total deformation energy and the terminal wrapping stage.Our results suggest that,in addition to the energy requirement,the success of passive endocytosis also depends on the maximum strength of the receptor-ligand bonds. 展开更多
关键词 receptor-mediated ENDOCYTOSIS NANOPARTICLE UPTAKE optimization method receptor-ligand BONDS drug delivery
下载PDF
上一页 1 2 6 下一页 到第
使用帮助 返回顶部